查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465998

血糖監測市場：按產品、測試技術、應用、分銷管道和最終用戶 - 全球預測 2024-2030

Blood Glucose Monitoring Market by Product, Testing Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年血糖監測市場規模為130.6億美元，預計2024年將達到140.8億美元，2030年將達228億美元，複合年成長率為8.28%。

血糖監測是指追蹤血液中血糖濃度的連續過程，這對於管理糖尿病的個人非常重要。這對於糖尿病患者來說極為重要。這種做法可以幫助您就飲食、運動和藥物治療做出明智的決定，有助於有效管理血糖值並降低糖尿病相關併發症的風險。糖尿病監測的使用增加主要是由於全球糖尿病盛行率不斷上升、提供更簡單和侵入性較小的監測方案的技術進步、對血糖控制重要性的認知提高以及綜合護理模式的發展都是一個因素。 。然而，頻繁的手指刺痛測試帶來的不適和疼痛、監測用品的成本以及由於使用者錯誤或設備故障而導致讀數不準確的可能性正在影響產品的採用。製造商專注於開發連續血糖監測儀 (CGM)，以減少用戶參與，提供無痛即時監測，並且可以與行動技術整合以增強資料追蹤和分析。血糖監測的未來機會非常豐富，包括非侵入性技術、用於預測分析的人工智慧 (AI) 以及有助於更個人化和高效的糖尿病管理的互連醫療設備。

主要市場統計
基準年[2023] 130.6億美元
預測年份 [2024] 140.8億美元
預測年份 [2030] 228億美元
複合年成長率（%） 8.28%

提供產品自我血糖監測的個人化指導。

連續血糖監測儀非常適合需要即時血糖監測的患者，尤其是第 1 型糖尿病患者或需要強化胰島素治療的患者。 CGM 是為那些從全天追蹤血糖濃度趨勢中受益的用戶開出的，可以實現更準確的胰島素劑量和整體血糖管理。與自我監測血糖（SMBG）設備相比，CGM 的優點是不需要重複皮膚穿刺並提供連續、動態的血糖濃度測量。 CGM可以降低高血糖和低血糖的發生率，提高生活品質，改善血糖控制。自我血糖監測設備適用於不需要持續監測但確實想定期檢查血糖值的人。它們適合第 1 型和第 2 型糖尿病患者，特別是那些透過飲食、運動、口服藥物或偶爾注射胰島素來控制病情的患者。 SMBG 設備提供測試時血糖值的簡介，因此與更複雜的 CGM 相比，需要更少的承諾和費用。然而，SMBG 依賴穿刺測試，這可能因不舒適和不便而對某些使用者沒有吸引力。

測試技術：電極式血糖儀開發為攜帶式和家用設備的潛力

電極血糖儀利用電化學反應來測量血液中的葡萄糖水平。將少量血液樣本放在含有與葡萄糖反應的酵素的試紙上。此反應會產生小電流，由電極測量並在監視器上顯示葡萄糖值。光電血糖儀應用光學測量原理，利用光來測量血液中的葡萄糖含量。光與試紙上的血液樣本相互作用，吸收的光量指示葡萄糖濃度。電極監測器可實現快速且高精度的測量，使其適用於醫療和緊急情況以及需要仔細管理的糖尿病患者。另一方面，光電監視器提供了一種非侵入性的替代方案，迎合了那些尋求舒適度和降低潛在重複成本的人的需求。

應用 需要對第 1 型糖尿病進行準確和持續監測的先進 CGM

妊娠糖尿病（GDM）的特徵是不同嚴重程度的葡萄糖耐受不良，通常在懷孕期間發生。 GDM 的血糖監測對於確保母親和胎兒發育的健康至關重要。鑑於病情的暫時性，GDM 患者需要準確且易於使用的監測工具來有效管理其血糖濃度。 1 型糖尿病患者需要終身胰島素治療和定期血糖監測。 1 型糖尿病需要終身胰島素治療和定期血糖控制，而 GDM 則需要提供即時讀數和趨勢資訊的連續血糖監測系統 (CGM)。 2 型糖尿病通常與生活方式有關，需要個人血糖監測儀進行定期檢查。患者可能更喜歡價格實惠且易於使用的血糖儀。具有連接性、允許儲存資料以進行長期監測的血糖監測儀將吸引這一細分市場。妊娠糖尿病強調具有先進資料管理和共用功能的間歇性監測解決方案。相比之下，1 型糖尿病監測解決方案優先考慮準確性和持續監測。另一方面，2 型糖尿病市場注重成本效率和易用性，因為患者通常需要平衡糖尿病管理與生活的其他方面。

最終用戶：提供血糖值監測儀，最佳化醫院的臨床效率和病患吞吐量。

居家照護主要涉及糖尿病患者或在非臨床環境中有糖尿病風險的患者使用的血糖監測解決方案。在家庭護理領域，使用者通常喜歡結構緊湊、易於使用且需要最少維護的設備。智慧型手機連接和用於遠端患者監護的無縫資料傳輸等功能正變得越來越受歡迎。準確性、可負擔性和微創技術也是居家醫療使用者的偏好。醫院和診所是血糖監測的另一個主要領域，注重準確性、即時監測、與醫院管理系統的整合，以及促進住院患者的全面護理。這些設施需要能夠支援大量患者的設備，為電子健康記錄(EHR) 整合提供強大的連接性，並確保準確、快速的測量，以便即時做出臨床決策。優選高品質、可靠且易於消毒的設備，以防止交叉污染問題。

區域洞察

由於糖尿病盛行率不斷上升，血糖監測設備在美洲已廣泛應用，尤其是在糖尿病治療市場成熟的美國。該地區系統生產的特點是高科技創新、嚴格的法律規範和大量的研發投資。美洲的主要企業提供先進的監測系統，包括連續血糖監測 (CGM) 設備和快速血糖監測系統。同時，在亞太地區（APAC），由於糖尿病人口的增加、醫療保健意識的提高以及醫療基礎設施的改善，血糖監測市場正在快速成長，特別是在中國和印度等新興經濟體。亞太地區的生產變得更具成本效益且更容易獲得，國際公司正在擴大其足跡，以滿足不斷成長的需求。雖然西歐以及美洲對創新、非侵入性監測技術的需求強勁，但中東和非洲是新興市場，其成本限制和不同水準的衛生基礎設施意味著基本的血糖監測系統受到重視。歐洲、中東和非洲地區的公司努力在引進先進產品和滿足該地區不同地區的承受能力之間取得平衡。

FPNV定位矩陣

FPNV定位矩陣對於評估血糖監測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血糖監測市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 血糖監測市場的市場規模與預測是多少？

2.在血糖監測市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3. 血糖監測市場的技術趨勢和法規結構是什麼？

4.血糖監測市場主要廠商的市場佔有率為何？

5.進入血糖監測市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高糖尿病盛行率和提高認知計劃
      • 人們越來越青睞非侵入性血糖監測技術
      • 持續居家照護的需要
    • 抑制因素
      • 回顧血糖監測系統的負面影響
    • 機會
      • 血糖監測系統的設計與功能的進步
      • 加強血糖監測報銷
    • 任務
      • 創建和操作血糖監測的複雜性
  • 市場區隔分析
    • 產品：提供自我血糖儀的個人指導
    • 測試技術：電極式血糖值監測儀被開發為攜帶式和家用設備的可能性
    • 應用：需要對第 1 型糖尿病進行精確連續監測的高級 CGM
    • 最終用戶：提供血糖值監測儀以最佳化醫院的臨床效率和患者吞吐量
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章血糖監測市場：依產品

  • 連續血糖監測儀
  • 自我或一次性監測

第7章 血糖監測市場測試技術

  • 電極式血糖值儀
  • 光電血糖值儀

第8章血糖監測市場：依應用分類

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第9章血糖監測市場：依通路分類

  • 離線
  • 線上

第10章血糖監測市場：依最終用戶分類

  • 居家護理
  • 醫院/診所

第11章美洲血糖監測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太血糖監測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲血糖監測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 雅培完成 Bigfoot Biomedical 的收購
    • Dexcom 推出新型穿戴式設備，無需胰島素即可協助管理第 2 型糖尿病
    • Astellas來製藥、Roche Diabetes Care Japan 和 Bluestar 簽署合作協議，開發綜合糖尿病自我管理解決方案並將其商業化
  • 戰略分析和建議

第15章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-957C47F90031

[194 Pages Report] The Blood Glucose Monitoring Market size was estimated at USD 13.06 billion in 2023 and expected to reach USD 14.08 billion in 2024, at a CAGR 8.28% to reach USD 22.80 billion by 2030.

Blood glucose monitoring refers to the ongoing process of tracking the levels of glucose in the bloodstream, which is crucial for individuals managing diabetes. This practice helps in making informed decisions regarding diet, exercise, and medication, contributing to the effective management of blood sugar levels and reducing the risk of diabetes-related complications. The expansion of its use is primarily driven by the growing prevalence of diabetes globally, advancements in technology that provide more convenient and less invasive monitoring options, increased awareness about the importance of glycemic control, and the development of integrated care models. However, discomfort and pain related to frequent finger-prick tests, the cost of monitoring supplies, and the potential for inaccurate readings due to user error or device malfunction impact the product adoption. Manufacturers are focusing on developing continuous glucose monitors (CGMs) that offer painless, real-time monitoring while reducing user involvement, as well as investing in smart devices that can integrate with mobile technology for enhanced data tracking and analysis. The future opportunities in blood glucose monitoring are abundant, with prospects of non-invasive techniques, artificial intelligence (AI) for predictive analytics, and interconnected healthcare devices that could contribute to a more personalized and efficient diabetes management landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 13.06 billion
Estimated Year [2024] USD 14.08 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 8.28%

Product: Provision of personalized guidance in self-monitoring blood glucose monitors

Continuous blood glucose monitors are ideal for patients who require real-time glucose monitoring, particularly those with Type 1 diabetes or those who have intensive insulin therapy needs. CGMs are prescribed for users who benefit from tracking trends in glucose levels throughout the day, enabling more precise insulin dosing and better overall glucose management. Compared to self-monitoring blood glucose (SMBG) devices, CGMs offer the advantage of providing continuous, dynamic glucose level readings without the need for repeated skin punctures. They can reduce the incidence of both hyperglycemia and hypoglycemia, enhance quality of life, and improve glycemic control. Self-monitoring blood glucose devices are used by individuals who may not need continuous monitoring but still require regular checks of their glucose levels. These are suited for patients with both Type 1 and Type 2 diabetes, particularly those who manage their condition through diet, exercise, oral medication, or occasional insulin injections. SMBG devices provide a snapshot of the glucose level at the time of testing, requiring less commitment and expense compared to the more sophisticated CGMs. However, SMBGs rely on puncture tests, which can be less appealing to some users due to discomfort or inconvenience.

Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices

Electrode-type blood glucose monitors function by utilizing electrochemical reactions to measure glucose levels in the blood. A small blood sample is placed on a test strip, which contains an enzyme that reacts with glucose. The reaction produces a small electrical current that is measured by the electrodes, and the glucose level is then displayed on the monitor. Photoelectric blood glucose monitors work on the principle of photometry and uses a beam of light to measure the amount of glucose in the blood. The light interacts with the blood sample on the test strip, and the amount of light absorbed indicates the glucose concentration. Electrode-type monitors offer quick and highly accurate measurements, which makes them suitable for medical and emergency settings, as well as for diabetic patients who closely manage their condition. On the other hand, photoelectric monitors provide a non-invasive alternative that caters to those who seek comfort and potentially lower repetitive costs.

Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes

Gestational diabetes mellitus (GDM) is characterized by glucose intolerance of varying severity and typically occurs during pregnancy. Blood glucose monitoring for GDM is critical to ensure the health of the mother and the developing fetus. Patients with GDM may have a specific need for monitoring tools with high accuracy and ease of use to manage glucose levels effectively, considering the temporary phase of their condition. Individuals with Type 1 Diabetes require lifelong insulin therapy and regular blood glucose monitoring. GDM requires continuous glucose monitoring systems (CGMs) that provide real-time readings and trend information, which can help in the tight management of their condition. Type 2 Diabetes, often related to lifestyle factors, requires personal blood glucose monitors for regular checks. Patients might prefer affordable and simple-to-use glucometers. Blood glucose monitors with connectivity features that can store data for long-term observation appeal to this segment. For gestational diabetes, the market emphasizes temporary monitoring solutions with advanced data management and sharing capabilities. In contrast, Type 1 Diabetes monitoring solutions prioritize accuracy and constant monitoring. Meanwhile, the market for Type 2 Diabetes focuses on cost-efficiency and ease of use, as patients often need to balance diabetes management with other life commitments.

End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals

Home care pertains to blood glucose monitoring solutions used by individuals with diabetes or at risk of developing diabetes, primarily in a non-clinical setting. In the home care segment, users typically prefer compact, easy-to-use devices with minimal maintenance. Features such as connectivity to smartphones and seamless data transfer for remote patient monitoring are increasingly popular. Accuracy, affordability, and minimally invasive technology are also high on the preference list for home care users. Hospitals and clinics represent another major segment for blood glucose monitoring, where the emphasis is on precision, real-time monitoring, integration with hospital management systems, and the facilitation of comprehensive care for inpatients. These establishments require devices that can support a high volume of patients, offer robust connectivity for electronic health records (EHR) integration, and ensure precise, quick readings to inform immediate clinical decisions. High-quality, reliable, and easily sterilizable devices are preferred to prevent cross-contamination issues.

Regional Insights

In the Americas, blood glucose monitoring devices are widely used, owing to the increasing prevalence of diabetes, particularly in the United States, which has a mature market for diabetes care. The production of these systems in this region is characterized by high technological innovation, stringent regulatory oversight, and substantial investments in research and development. Major companies based in the Americas provide advanced monitoring systems, including continuous glucose monitoring (CGM) devices and flash glucose monitoring systems. On the other hand, in the Asia-Pacific (APAC) region, there is rapid growth in the blood glucose monitoring market, fueled by the rising diabetic population, growing healthcare awareness, and improving healthcare infrastructure, particularly in emerging economies such as China and India. Production in APAC tends to focus on cost-effectiveness and accessibility, with international companies expanding their footprint to capture the burgeoning demand. Western Europe shows a strong demand for innovative and non-invasive monitoring technologies similar to the Americas, while the Middle East and Africa are emerging markets with a focus on basic glucose monitoring systems due to cost constraints and varying levels of healthcare infrastructure. Companies in the EMEA region are working to strive to balance between introducing advanced products and catering to affordability in different parts of the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Glucose Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Glucose Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Continuous Blood Glucose Monitors
      • Insulin Pumps
      • Sensors
      • Transmitter & Receiver
    • Self or One Time Monitors
      • Blood Glucose Meter
      • Lancets
      • Testing Strips
  • Testing Technology
    • Electrode Type Blood Glucose Monitor
    • Photoelectric Blood Glucose Monitor
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Home Care
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Glucose Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Glucose Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Blood Glucose Monitoring Market?

4. What is the market share of the leading vendors in the Blood Glucose Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Blood Glucose Monitoring Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes and improved awareness programs
      • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
      • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
      • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
    • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
    • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
    • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Glucose Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Blood Glucose Monitors
  • 6.3. Self or One Time Monitors

7. Blood Glucose Monitoring Market, by Testing Technology

  • 7.1. Introduction
  • 7.2. Electrode Type Blood Glucose Monitor
  • 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care
  • 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
    • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
    • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 218. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 291. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 302. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 303. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 304. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 305. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)